Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-26 @ 10:58 AM
Ignite Modification Date:
2025-12-26 @ 10:58 AM
NCT ID:
NCT01363206
Brief Title:
Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma
Official Title:
GM-CSF and Ipilimumab as Therapy in Metastatic Melanoma, a Phase II Study
Acronym:
GIPI
Study:
NCT01363206
Protocol Section:
NCT01363206